| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | INFLUENZA M2 PROTEIN MUTANT VIRUSES AS LIVE INFLUENZA ATTENUATED VACCINES | US15292595 | 2016-10-13 | US20170096645A1 | 2017-04-06 | Tokiko Watanabe; Yoshihiro Kawaoka |
| A method to prepare recombinant influenza viruses comprising a mutant M2 protein which has a deletion of two or more residues in the cytoplasmic tail and is attenuated in vivo, is provided, as well the resulting virus and vaccines with the virus. | ||||||
| 2 | Tilapia lake virus vaccines | US15645718 | 2017-07-10 | US10071152B2 | 2018-09-11 | Eran Bacharach; Avi Eldar |
| The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease. | ||||||
| 3 | TILAPIA LAKE VIRUS VACCINES | US15117833 | 2015-02-11 | US20160354458A1 | 2016-12-08 | Eran Bacharach; Avi Eldar |
| The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease. | ||||||
| 4 | Influenza M2 protein mutant viruses as live influenza attenuated vaccines | US15292595 | 2016-10-13 | US10119124B2 | 2018-11-06 | Tokiko Watanabe; Yoshihiro Kawaoka |
| A method to prepare recombinant influenza viruses comprising a mutant M2 protein which has a deletion of two or more residues in the cytoplasmic tail and is attenuated in vivo, is provided, as well the resulting virus and vaccines with the virus. | ||||||
| 5 | TILAPIA LAKE VIRUS VACCINES | US15645718 | 2017-07-10 | US20180008692A1 | 2018-01-11 | Eran Bacharach; Avi Eldar |
| The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease. | ||||||
| 6 | Tilapia lake virus vaccines | US15117833 | 2015-02-11 | US09730998B2 | 2017-08-15 | Eran Bacharach; Avi Eldar |
| The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease. | ||||||
| 7 | Influenza M2 protein mutant viruses as live influenza attenuated vaccines | US12214414 | 2008-06-18 | US09474798B2 | 2016-10-25 | Tokiko Watanabe; Yoshihiro Kawaoka |
| A method to prepare recombinant influenza viruses comprising a mutant M2 protein which has a deletion of two or more residues in the cytoplasmic tail and is attenuated in vivo, is provided, as well the resulting virus and vaccines with the virus. | ||||||
| 8 | Influenza M2 protein mutant viruses as live influenza attenuated vaccines | US12214414 | 2008-06-18 | US20090074812A1 | 2009-03-19 | Tokiko Watanabe; Yoshihiro Kawaoka |
| A method to prepare recombinant influenza viruses comprising a mutant M2 protein which has a deletion of two or more residues in the cytoplasmic tail and is attenuated in vivo, is provided, as well the resulting virus and vaccines with the virus. | ||||||
| 9 | TILAPIA LAKE VIRUS VACCINES | EP18154927.0 | 2015-02-11 | EP3342422A1 | 2018-07-04 | BACHARACH, Eran; ELDAR, Avi |
The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease. |
||||||
| 10 | TILAPIA LAKE VIRUS VACCINES | EP15749196 | 2015-02-11 | EP3104883A4 | 2017-08-23 | BACHARACH ERAN; ELDAR AVI |
| The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease. | ||||||
| 11 | TILAPIA LAKE VIRUS VACCINES | EP15749196.0 | 2015-02-11 | EP3104883A1 | 2016-12-21 | BACHARACH, Eran; ELDAR, Avi |
| The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease. | ||||||
| 12 | INFLUENZA M2 PROTEIN MUTANT VIRUSES AS LIVE INFLUENZA ATTENUATED VACCINES | PCT/US2008007582 | 2008-06-18 | WO2008156778A9 | 2009-02-12 | WATANABE TOKIKO; KAWAOKA YOSHIHIRO |
| A method to prepare recombinant influenza viruses comprising a mutant M2 protein which has a deletion of two or more residues in the cytoplasmic tail and is attenuated in vivo, is provided, as well the resulting virus and vaccines with the virus. | ||||||
| 13 | INFLUENZA M2 PROTEIN MUTANT VIRUSES AS LIVE INFLUENZA ATTENUATED VACCINES | PCT/US2008007582 | 2008-06-18 | WO2008156778A2 | 2008-12-24 | WATANABE TOKIKO; KAWAOKA YOSHIHIRO |
| A method to prepare recombinant influenza viruses comprising a mutant M2 protein which has a deletion of two or more residues in the cytoplasmic tail and is attenuated in vivo, is provided, as well the resulting virus and vaccines with the virus. | ||||||
QQ群二维码
意见反馈
意见反馈